BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19840363)

  • 21. Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding.
    Cheng H; Yan R; Li S; Yuan Y; Liu J; Ruan C; Dai K
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2128-35. PubMed ID: 19820200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations.
    Tait AS; Cranmer SL; Jackson SP; Dawes IW; Chong BH
    Blood; 2001 Sep; 98(6):1812-8. PubMed ID: 11535515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of glycoprotein Ib-IX-von Willebrand factor interaction by cAMP-dependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(beta).
    Bodnar RJ; Xi X; Li Z; Berndt MC; Du X
    J Biol Chem; 2002 Dec; 277(49):47080-7. PubMed ID: 12361948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
    Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC
    Platelets; 2010; 21(4):244-52. PubMed ID: 20367574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.
    Cauwenberghs N; Vanhoorelbeke K; Vauterin S; Westra DF; Romo G; Huizinga EG; Lopez JA; Berndt MC; Harsfalvi J; Deckmyn H
    Blood; 2001 Aug; 98(3):652-60. PubMed ID: 11468163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional 14-3-3zeta-independent association of PI3-kinase with glycoprotein Ib alpha, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex.
    Mu FT; Andrews RK; Arthur JF; Munday AD; Cranmer SL; Jackson SP; Stomski FC; Lopez AF; Berndt MC
    Blood; 2008 May; 111(9):4580-7. PubMed ID: 18299448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
    Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
    J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction.
    Broos K; Trekels M; Jose RA; Demeulemeester J; Vandenbulcke A; Vandeputte N; Venken T; Egle B; De Borggraeve WM; Deckmyn H; De Maeyer M
    J Biol Chem; 2012 Mar; 287(12):9461-72. PubMed ID: 22232560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress.
    Auton M; Sowa KE; Smith SM; Sedlák E; Vijayan KV; Cruz MA
    J Biol Chem; 2010 Jul; 285(30):22831-9. PubMed ID: 20498367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
    Ju L; Dong JF; Cruz MA; Zhu C
    J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
    Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
    J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
    Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
    Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear.
    Hrdinova J; Fernández DI; Ercig B; Tullemans BME; Suylen DPL; Agten SM; Jurk K; Hackeng TM; Vanhoorelbeke K; Voorberg J; Reutelingsperger CPM; Wichapong K; Heemskerk JWM; Nicolaes GAF
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
    Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
    Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα.
    Shen C; Mackeigan DT; Shoara AA; Xu R; Bhoria P; Karakas D; Ma W; Cerenzia E; Chen Z; Hoard B; Lin L; Lei X; Zhu G; Chen P; Johnson PE; Ni H
    J Thromb Haemost; 2023 May; 21(5):1274-1288. PubMed ID: 36732162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human signaling protein 14-3-3zeta interacts with platelet glycoprotein Ib subunits Ibalpha and Ibbeta.
    Calverley DC; Kavanagh TJ; Roth GJ
    Blood; 1998 Feb; 91(4):1295-303. PubMed ID: 9454760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelets with a W127X mutation in GPIX express sufficient residual amounts of GPIbα to support adhesion to von Willebrand factor and collagen.
    Takata Y; Kanaji T; Moroi M; Seki R; Sano M; Nakazato S; Sueoka E; Imamura Y; Okamura T
    Int J Hematol; 2012 Dec; 96(6):733-42. PubMed ID: 23143686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet glycoprotein Ib beta/IX mediates glycoprotein Ib alpha localization to membrane lipid domain critical for von Willebrand factor interaction at high shear.
    Geng H; Xu G; Ran Y; López JA; Peng Y
    J Biol Chem; 2011 Jun; 286(24):21315-23. PubMed ID: 21507943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.